Study: Oral Cancer May Be Costliest to Treat

Share on Facebook
Oral cavity, oral pharyngeal and salivary gland cancers may be the costliest cancers to treat in the United States, according to a study in Head & Neck Oncology.

Researchers studied cost data for OC/OP/SG cancer patients compared with costs for patients without this type of cancer. They found total annual healthcare spending for OC/OP/SG patients with commercial insurance one year after diagnosis was $79,151 compared with $7,419 for people without OC/OP/SG cancer, indicating the cost burden of oral cancer was $71,732 for these patients. The cost burden was $35,890 for Medicare patients and $44,541 for Medicaid patients.

The authors suggested the cost of treatment for OC/OP/SG cancer may be the highest compared with costs for other cancers, which range from $31,559 to $65,123, according to other studies the authors cited.

More Articles on Cancer Costs:

Medical Oncologists' Reimbursement Incentivizes Choosing High-Cost Meds
Study: Cancer Patients' Higher Survival in U.S. vs. Europe "Worth" the Extra Costs

Study: Chemotherapy Patient Care Costs 24% More in Hospital Outpatient Setting Than in Physician Office

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.